1.Acute Renal Failure in Children: Underlying Disease and Management according to Age.
Eun Joung PARK ; Joung Sim KIM ; Jai Bok YOO ; Joung Sook SUL ; Si Whan KOH ; Phil Soo OH ; I Suk KANG ; Moon Soo PARK ; Heung Jae LEE ; Dong Kyoo JIN
Journal of the Korean Pediatric Society 1998;41(5):654-662
PURPOSE: It has been stressed that age itself as well as multiple organ failure are important prognostic factors in acute renal failure (ARF) in children. This study was performed to find out the significance of age factor and underlying disease of ARF in children. METHODS: We tried to review 58 pediatric ARF cases, retrospectively, in the pediatric intensive care unit (excluding the neonatal and surgical intensive care unit cases) of the Samsung Seoul Hospital of Sung Kyun Kwan University from Sept., 1994. to Dec., 1996. RESULTS: We classified the enrolled 58 cases into 5 age groups and more than half were younger than 1 year old. As underlying causes, heart and gastrointestinal disease were predominant in less than 1 month of age group. After 1 year of age, intrinsic renal disease was the most common cause (43-50%). Among the renal disease, systemic lupus erythematosus (10-15 year group), hemolytic uremic syndrome (1-10 year group), and obstructive uropathy (less than 1 year age group) were common etiologies. The mortality was the highest (46.7%) in less than 1 year group and lowest (21.4%) in 10-15 year age group. CONCLUSION: The underlying disorders of ARF in children were different among the age group. Among intrinsic renal diseases, hemolytic uremic syndrome was the most common cause. The difference in the mortality was dependent on age and underlying disease.
Acute Kidney Injury*
;
Age Factors
;
Child*
;
Gastrointestinal Diseases
;
Heart
;
Hemolytic-Uremic Syndrome
;
Humans
;
Critical Care
;
Intensive Care Units
;
Lupus Erythematosus, Systemic
;
Mortality
;
Multiple Organ Failure
;
Retrospective Studies
;
Seoul
2.WebChemDB: An Integrated Chemical Database Retrieval System.
Bo Kyeng HOU ; Eun Joung MOON ; Sung Chul MOON ; Hae Jin KIM
Genomics & Informatics 2009;7(4):212-216
WebChemDB is an integrated chemical database retrieval system that provides access to over 8 million publicly available chemical structures, including related information on their biological activities and direct links to other public chemical resources, such as PubChem, ChEBI, and DrugBank. The data are publicly available over the web, using two-dimensional (2D) and three-dimensional (3D) structure retrieval systems with various filters and molecular descriptors. The web services API also provides researchers with functionalities to programmatically manipulate, search, and analyze the data.
Databases, Chemical
;
Subject Headings
3.A Clinical Study on Hereditary Spherocytosis.
Joung Chul PARK ; Jun Eun PARK ; Yoon Jeong KIM ; Jong Jin SEO ; Hyung Nam MOON ; Thad GHIM
Korean Journal of Pediatric Hematology-Oncology 2000;7(1):9-15
PURPOSE: The aim of this study was to investigate the clinical and laboratory findings of hereditary spherocytosis comparing those of different age groups. METHODS: The clinical and laboratory findings of hereditary spherocytosis from June 1989 to August 1998 at Asan Medical Center were analyzed retrospectively according to two different age groups, Group I (9 patients diagnosed under 10 years of age) and Group II (19 patients diagnosed at or over 10 years of age). RESULTS: 1) Mean age at diagnosis was 2.4+/-1.97 and 28.2+/-18.81 years, and family history was positive in 44% and 47% in Group I and II patients respectively. 2) Splenectomy was carried out in 33% and 79% of Group I and II patients respectively, and accessory spleen was found in 100% and 20% of splenectomized patients respectively. 3) Gallstone was found in 11% and 42% of Group I and II patients respectively, and aplastic crisis developed in 0% and 10% respectively. 4) Post-splenectomy hematological parameters improved as follows: Group I; from hemoglobin at diagnosis of 8.5+/-3.59 g/dL to post-splenectomy level of 12.6+/-0.86 g/dL, hematocrit 24.5+/-10.25% to 38.1+/-4.86%, corrected reticulocyte 9.0+/-4.16% to 1.2+/-0.84%, total bilirubin 3.2+/-1.53 mg/dL to 2.2+/-1.34 mg/dL. Group II ; from hemoglobin at diagnosis of 8.9+/-2.95 g/dL to post-splenectomy level of 12.6+/-1.27 g/dL, hematocrit 24.9+/-7.85% to 37.4+/-2.89%, corrected reticulocyte 4.8+/-2.74% to 2.0+/-1.12%, total bilirubin 5.2+/-5.05 mg/dL to 1.1+/-0.49 mg/dL. CONCLUSION: There were no age related differences in hematologic findings at diagnosis and many of the patients with milder form of the disease could be detected later in adult life. The frequency of gallstone was up to 42% in patients whose diagnosis was delayed after 10 years of age, and aplastic crisis was a rare complication. Splenectomy was an effective treatment leading to normal hemoglobin concentrations in all patients. Accessory spleen was found in 33% of splenectomized patients, which emphasizes the necessity of spleen scan before splenectomy.
Adult
;
Bilirubin
;
Chungcheongnam-do
;
Diagnosis
;
Gallstones
;
Hematocrit
;
Humans
;
Reticulocytes
;
Retrospective Studies
;
Spleen
;
Splenectomy
4.Regulation of LIF Gene Expression by Interleukin-1 in the Mouse Peri-implantation Embryos and Uterine Endometiral Cells.
Joung Woul KIM ; Hye Young YANG ; Hyoung Eun RYU ; Ji Youn LEE ; Moon Kyoo KIM ; Jung Bok LEE ; Hyun Soo YOON
Korean Journal of Fertility and Sterility 2000;27(2):183-190
No abstract available.
Animals
;
Embryonic Structures*
;
Gene Expression*
;
Interleukin-1*
;
Mice*
5.Hypoxia activates the cyclin D1 promoter via the Jak2/STAT5b pathway in breast cancer cells.
Youn Hee JOUNG ; Eun Joung LIM ; Moon Young LEE ; Jong Hwan PARK ; Sang Kyu YE ; Eui U PARK ; Sang Yoon KIM ; Zheng ZHANG ; Kwang Jeon LEE ; Dong Ki PARK ; Taekyu PARK ; Won Kook MOON ; Young Mok YANG
Experimental & Molecular Medicine 2005;37(4):353-364
Hypoxia, a common consequence of solid tumor growth in breast cancer or other cancers, serves to propagate a cascade of molecular pathways which include angiogenesis, glycolysis, and various cellcycle control proteins. As we have shown previously, hypoxia activates STAT5 (signal transducer and activator of transcription 5) and increases its binding activity to the GAS element in mammary epithelial cells. In this study we attempted to elucidate the mechanism by which cyclin D1 is regulated by the STAT5 protein under hypoxic conditions. Our data demonstrate that hypoxia (2% O2) or desferrioxamine (DFO) induces tyrosine and serine phosphorylation of STAT5 in human breast cancer cells (MCF-7) and mammary epithelial cells (HC11). Imunoprecipitation and subsequent Western analysis showed that Jak2 leads to the tyrosine phosphorylation and activation of STAT5a or STAT5b under hypoxic conditions. Using a transfected COS-7 cell model system, we demonstrate that the activity of a cyclin D1 promoter-luciferase construct increased under hypoxic conditions or DFO treatment. The activity of the STAT5b/cyclin D1 promoter increased significantly by 12 h of hypoxia, whereas the activity of the STAT5a/cyclin D1 promoter was unaffected under hypoxic conditions. These increases in promoter activity are predominantly mediated by the Jak2/ STAT5b signaling pathway. We have shown by EMSA that hypoxia induces STAT5 to bind to the cyclin D1 promoter (GAS-1) in MCF-7 and HC11 cells. These data suggest that STAT5b may mediate the transcriptional activation of cyclin D1 after hypoxic stimulation.
Anaerobiosis/genetics
;
Animals
;
Breast Neoplasms/*genetics/metabolism
;
COS Cells
;
Cell Hypoxia/genetics
;
Cercopithecus aethiops
;
Cyclin D1/*genetics
;
Deferoxamine/pharmacology
;
Female
;
*Gene Expression Regulation, Neoplastic
;
Humans
;
Phosphorylation/drug effects
;
Promoter Regions (Genetics)
;
Protein-Tyrosine Kinase/*metabolism
;
Proto-Oncogene Proteins/*metabolism
;
Research Support, Non-U.S. Gov't
;
Serine/metabolism
;
Tumor Cells, Cultured
;
Tyrosine/metabolism
6.Proteomic Analysis of Serum from Patients with Major Depressive Disorder to Compare Their Depressive and Remission Statuses.
Jiyeong LEE ; Eun Jeong JOO ; Hee Joung LIM ; Jong Moon PARK ; Kyu Young LEE ; Arum PARK ; Aeeun SEOK ; Hookeun LEE ; Hee Gyoo KANG
Psychiatry Investigation 2015;12(2):249-259
OBJECTIVE: Currently, there are a few biological markers to aid in the diagnosis and treatment of depression. However, it is not sufficient for diagnosis. We attempted to identify differentially expressed proteins during depressive moods as putative diagnostic biomarkers by using quantitative proteomic analysis of serum. METHODS: Blood samples were collected twice from five patients with major depressive disorder (MDD) at depressive status before treatment and at remission status during treatment. Samples were individually analyzed by liquid chromatography-tandem mass spectrometry for protein profiling. Differentially expressed proteins were analyzed by label-free quantification. Enzyme-linked immunosorbent assay (ELISA) results and receiver-operating characteristic (ROC) curves were used to validate the differentially expressed proteins. For validation, 8 patients with MDD including 3 additional patients and 8 matched normal controls were analyzed. RESULTS: The quantitative proteomic studies identified 10 proteins that were consistently upregulated or downregulated in 5 MDD patients. ELISA yielded results consistent with the proteomic analysis for 3 proteins. Expression levels were significantly different between normal controls and MDD patients. The 3 proteins were ceruloplasmin, inter-alpha-trypsin inhibitor heavy chain H4 and complement component 1qC, which were upregulated during the depressive status. The depressive status could be distinguished from the euthymic status from the ROC curves for these proteins, and this discrimination was enhanced when all 3 proteins were analyzed together. CONCLUSION: This is the first proteomic study in MDD patients to compare intra-individual differences dependent on mood. This technique could be a useful approach to identify MDD biomarkers, but requires additional proteomic studies for validation.
Biomarkers
;
Ceruloplasmin
;
Complement System Proteins
;
Depression
;
Depressive Disorder, Major*
;
Diagnosis
;
Discrimination (Psychology)
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Inflammation
;
Mass Spectrometry
;
Neurotransmitter Agents
;
Proteomics
;
ROC Curve
7.Characterization of H460R, a Radioresistant Human Lung Cancer Cell Line, and Involvement of Syntrophin Beta 2 (SNTB2) in Radioresistance.
Chang Nim IM ; Byeong Mo KIM ; Eun Yi MOON ; Da Won HONG ; Joung Whan PARK ; Sung Hee HONG
Genomics & Informatics 2013;11(4):245-253
A radioresistant cell line was established by fractionated ionizing radiation (IR) and assessed by a clonogenic assay, flow cytometry, and Western blot analysis, as well as zymography and a wound healing assay. Microarray was performed to profile global expression and to search for differentially expressed genes (DEGs) in response to IR. H460R cells demonstrated increased cell scattering and acidic vesicular organelles compared with parental cells. Concomitantly, H460R cells showed characteristics of increased migration and matrix metalloproteinase activity. In addition, H460R cells were resistant to IR, exhibiting reduced expression levels of ionizing responsive proteins (p-p53 and gamma-H2AX); apoptosis-related molecules, such as cleaved poly(ADP ribose) polymerase; and endoplasmic reticulum stress-related molecules, such as glucose-regulated protein (GRP78) and C/EBP-homologous protein compared with parental cells, whereas the expression of anti-apoptotic X-linked inhibitor of apoptosis protein was increased. Among DEGs, syntrophin beta 2 (SNTB2) significantly increased in H460R cells in response to IR. Knockdown of SNTB2 by siRNA was more sensitive than the control after IR exposure in H460, H460R, and H1299 cells. Our study suggests that H460R cells have differential properties, including cell morphology, potential for metastasis, and resistance to IR, compared with parental cells. In addition, SNTB2 may play an important role in radioresistance. H460R cells could be helpful in in vitro systems for elucidating the molecular mechanisms of and discovering drugs to overcome radioresistance in lung cancer therapy.
Apoptosis
;
Blotting, Western
;
Cell Line*
;
Endoplasmic Reticulum
;
Flow Cytometry
;
Humans*
;
Lung Neoplasms*
;
Lung*
;
Matrix Metalloproteinases
;
Neoplasm Metastasis
;
Organelles
;
Parents
;
Radiation, Ionizing
;
RNA, Small Interfering
;
Wound Healing
;
X-Linked Inhibitor of Apoptosis Protein
8.Effect of Sex Offenders Treatment Programme on Cognitive and Emotional Characteristics of Mentally Ill Sex-Offenders.
Jeong Hyun KIM ; Sang Sub CHOI ; Moon Sung RHEE ; Sun Bum KIM ; Ji Sook JOUNG ; Eun Hye KIM ; Mi Kyung LYU
Journal of Korean Neuropsychiatric Association 2007;46(6):579-586
OBJECTIVES: This study was investigated to prove the effectiveness of Cognitive Behavior Treatment Program in mentally ill sex offenders and to be used as basic data for development of optimized treatment program for mentally ill sex offenders. METHODS: Cognitive Behavior Treatment Program was carried out over 10 weeks for 30 mentally ill sex offenders. With Interpersonal Responsiveness Index (IRI), UCLA Loneliness Scale (UCLALS), Coping Using Sex Inventory (CUSI) and Rape Myth Acceptance Scale (RMAS), the effectiveness of the treatment programme was evaluated. The data was analyzed with paired t-test. RESULTS: The results with 23 subjects showed no significant score changes after treatment program in IRI and UCLALS. However, there was a statistically significant improvement in the scores of CUSI and RMAS. CONCLUSION: Despite several limitations, this study showed significant effects of Cognitive Behavior Treatment Program on mentally-ill sex offenders. Therefore, treatment focused on the changes of cognitive and emotional characteristics of sex offenders along with the treatment for main psychiatric illness should be provided for mentally ill sex offenders to prevent recidivism. More studies to develope optimized treatment programme for mentally ill sex offenders are needed in the future.
Criminals*
;
Humans
;
Loneliness
;
Mentally Ill Persons*
;
Rape
9.Biochemical Markers as Predictors of In-Hospital Mortality in Patients with Severe Trauma: A Retrospective Cohort Study.
Ha Nee JANG ; Hyun Oh PARK ; Tae Won YANG ; Jun Ho YANG ; Sung Hwan KIM ; Seong Ho MOON ; Joung Hun BYUN ; Chung Eun LEE ; Jong Woo KIM ; Dong Hun KANG ; Kyeong Hee BAEK
Korean Journal of Critical Care Medicine 2017;32(3):240-246
BACKGROUND: Initial evaluation of injury severity in trauma patients is an important and challenging task. We aimed to assess whether easily measurable biochemical parameters (hemoglobin, pH, and prothrombin time/international normalized ratio [PT/INR]) can predict in-hospital mortality in patients with severe trauma. METHODS: This retrospective study involved review of the medical records of 315 patients with severe trauma and an injury severity score >15 who were managed at Gyeongsang National University Hospital between January 2005 and December 2015. We extracted the following data: in-hospital mortality, injury severity score, and initial hemoglobin level, pH, and PT/INR. The predictive values of these variables were compared using receiver operation characteristic curves. RESULTS: Of the 315 patients, 72 (22.9%) died. The in-hospital mortality rates of patients with hemoglobin levels <8.4 g/dl and ≥8.4 g/dl were 49.8% and 9.9%, respectively (P < 0.001). At a cutoff hemoglobin level of 8.4 g/dl, the sensitivity and specificity values for mortality were 81.9% and 86.4%, respectively. At a pH cutoff of 7.25, the sensitivity and specificity values for mortality were 66.7% and 77.8%, respectively; 66.7% of patients with a pH <7.25 died versus 22.2% with a pH ≥7.25 (P < 0.001). The in-hospital mortality rates for patients with PT/INR values ≥1.4 and <1.4 were 37.5% and 16%, respectively (P < 0.001; sensitivity, 37.5%; specificity, 84%). CONCLUSIONS: Using the suggested cutoff values, hemoglobin level, pH, and PT/INR can simply and easily be used to predict in-hospital mortality in patients with severe trauma.
Acidosis
;
Biomarkers*
;
Cohort Studies*
;
Hospital Mortality*
;
Humans
;
Hydrogen-Ion Concentration
;
Injury Severity Score
;
International Normalized Ratio
;
Medical Records
;
Mortality
;
Prothrombin
;
Retrospective Studies*
;
Sensitivity and Specificity
10.A Case of Antiphospholipid Antibody Syndrome Accompanied by Valvular Heart Disease and Moya Moya Syndrome.
Sung Ho CHOI ; Bo Young JOUNG ; Dongsoo KIM ; Jae Phil CHOI ; Min Ho CHO ; Sung Ju LEE ; Sang Hak LEE ; Byung Eun PARK ; Bum Kee HONG ; Hyuck Moon KWON ; Chanil PARK ; Tae Sub CHUNG ; Hyun Seung KIM
Korean Circulation Journal 2003;33(7):620-624
A case of antiphospholipid antibody syndrome, accompanied by valvular heart disease and Moya moya syndrome, has never been reported. Here, we report on a case that had mitral regurgitation and Moya moya syndrome, associated with antiphospholipid antibody syndrome secondary to systemic lupus erythematosus. This patient underwent a mitral valve replacement for mitral valve regurgitation. The postoperative course was uneventful, and the pathological findings of the mitral valve showed a degenerative change, due to chronic inflammation, a proliferative fibrous change and calcification, but without thrombus formation. However, the patient returned to the hospital with a cerebral hemorrhage, which was caused by Moya moya syndrome. Surgical drainage was performed, and the patient was discharged without any complications. The patient is on anticoagulation and immunosuppression drugs, with no problems to date.
Antibodies, Antiphospholipid*
;
Antiphospholipid Syndrome*
;
Cerebral Hemorrhage
;
Drainage
;
Heart Valve Diseases*
;
Humans
;
Immunosuppression
;
Inflammation
;
Lupus Erythematosus, Systemic
;
Mitral Valve
;
Mitral Valve Insufficiency
;
Thrombosis